Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers
Status:
Completed
Trial end date:
2019-09-04
Target enrollment:
Participant gender:
Summary
This study is a randomized, open-label, fasted, single dose, crossover study to investigate
the pharmacokinetic profiles and safety of CKD-333 in healthy volunteers.